Back to Home
21st Annual New York Lung Cancers Symposium®
Live Event

21st Annual New York Lung Cancers Symposium®

November 14, 2026

Overview

At the New York Lung Cancers Symposium® attendees will experience a comprehensive overview of multidisciplinary lung cancer treatment. Now in its 21st year, this meeting is designed to increase your knowledge of lung cancer therapy, including the roles that surgery, radiology, pulmonology, and pathology play to ensure the most accurate diagnosis of lung cancers. You will hear thought leaders from the New York area discuss optimal approaches for early-stage and locally advanced disease, as well as present the latest data on immunotherapy and targeted agents in metastatic lung cancers. These multidisciplinary interactions will be illustrated in a tumor board format, which will also allow participants to present questions and clinical challenges from their practice.

The ever-popular interactive case challenges will provide you with an opportunity to discuss the application of clinical data for real-world patient cases. A special session has been designed for nurse practitioners and physician assistants, to provide a tailored experience for learning and networking.

We look forward to seeing you at the 21st Annual New York Lung Cancers Symposium® and are confident it will help foster collaboration between you and other members of the multidisciplinary oncology team. This is a program you won’t want to miss!

Program Co-Chairs

Balazs Halmos, MD, MS; Jamie Chaft, MD

To view full profile, click on the Program Co-Chairs tab above.

Event Details

  • Event Date
    November 14, 2026
  • Location
    New York, NY
  • Venue
    New York Hilton Midtown
    1335 Avenue of the Americas
    New York, NY 10019
    Phone: 212-586-7000
    View Accommodations
  • Target Audience
    This educational activity is directed toward medical oncologists along with surgeons, radiologists, general scientists, young investigators, advanced practice providers, nurses, and pharmacists who manage patients with lung cancers. Other health care professionals interested in the treatment of lung cancer are also invited to participate.

PER is proud to partner with Lungevity.

Related Content

View All